MCID: PSD007
MIFTS: 47

Pseudomyxoma Peritonei malady

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Pseudomyxoma Peritonei

About this section
Sources:
11Disease Ontology, 13DISEASES, 31ICD10 via Orphanet, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 54Orphanet, 62SNOMED-CT, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Pseudomyxoma Peritonei:

Name: Pseudomyxoma Peritonei 11 48 54 50 39 13 68
Pmp 48 54
Syndrome of Pseudomyxoma Peritonei 48
 
Gelatinous Ascites 54
Mucinous Ascites 11
Adenomucinosis 54

Characteristics:

Orphanet epidemiological data:

54
pseudomyxoma peritonei:
Prevalence: 1-9/1000000 (Worldwide); Age of onset: Adult; Age of death: any age

Classifications:



External Ids:

Disease Ontology11 DOID:3559
MeSH39 D011553
NCIt45 C3345
Orphanet54 ORPHA26790
MESH via Orphanet40 D011553
UMLS via Orphanet69 C0033822
ICD10 via Orphanet31 C78.6

Summaries for Pseudomyxoma Peritonei

About this section
NIH Rare Diseases:48 Pseudomyxoma peritonei (PMP) is a rare condition characterized by the presence of mucin in the abdominal (peritoneal) cavity. While the most common cause of PMP is appendix cancer, several types of tumors (including non-cancerous tumors) can cause PMP. Signs and symptoms may include an increase in abdominal size or bloating; inguinal hernia (in men); an ovarian mass, felt during a routine pelvic exam (in women); pain or discomfort in the abdomen; and/or appendicitis. Treatment depends on the underlying cause of the condition (the location and type of the original tumor, including whether it is malignant) and the extent of spreading. A combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is often the most successful treatment, and can achieve overall survival outcomes of up to 84% at 5 years. Last updated: 12/28/2016

MalaCards based summary: Pseudomyxoma Peritonei, also known as pmp, is related to peritonitis and ovarian cystadenocarcinoma, and has symptoms including ascites, abnormality of the peritoneum and abnormality of the abdominal wall. An important gene associated with Pseudomyxoma Peritonei is MUC2 (Mucin 2, Oligomeric Mucus/Gel-Forming), and among its related pathways are O-linked glycosylation and Defective GALNT12 causes colorectal cancer 1 (CRCS1). Affiliated tissues include appendix, colon and small intestine.

Disease Ontology:11 An appendix cancer that is characterized by progressive accumulation of mucus-secreting tumor cells within the abdomen and pelvis.

Wikipedia:71 Pseudomyxoma peritonei (PMP) is a clinical condition caused by cancerous cells (mucinous adenocarcinoma)... more...

Related Diseases for Pseudomyxoma Peritonei

About this section

Diseases related to Pseudomyxoma Peritonei via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 197)
idRelated DiseaseScoreTop Affiliating Genes
1peritonitis31.6KRT20, KRT7
2ovarian cystadenocarcinoma29.8MUC1, MUC2
3colorectal cancer26.9CDX2, KRAS, KRT20, MUC1, MUC2, MUC5AC
4mucinous adenocarcinoma11.5
5gelatinous ascites11.4
6adenocarcinoma10.5
7oral leukoedema10.5KRT20, KRT7
8carbuncle10.5KRT20, MUC2
9signet ring basal cell carcinoma10.5KRT20, KRT7
10mediastinal melanocytic neurilemmoma10.5KRT20, KRT7
11rectum adenoma10.5KRT20, KRT7
12sphenoid sinus squamous cell carcinoma10.5KRT20, KRT7
13punctate porokeratosis10.5KRT20, KRT7
14internal hordeolum10.5KRT20, KRT7
15multicentric reticulohistiocytosis10.5KRT20, KRT7
16heel spur10.5KRT20, KRT7
17vulva squamous cell carcinoma10.5KRT20, KRT7
18fallopian tube germ cell cancer10.5KRT20, KRT7
19pigmented villonodular synovitis10.5CDX2, KRT7
20eccrine adenocarcinoma10.5KRT20, KRT7
21cervix squamous papilloma10.5CDX2, MUC2
22cervical wilms' tumor10.4CDX2, KRT7
23uterine benign neoplasm10.4KRT20, KRT7
24rectal neoplasm10.4KRT20, KRT7
25pyloric antrum cancer10.4CDX2, MUC2
26chronic eustachian salpingitis10.4CDX2, KRT20
27moderately severe hemophilia a10.4MUC2, MUC5AC
28cystadenocarcinoma10.4
29subareolar duct papillomatosis10.4KRT7, MUC5AC
30polysyndactyly with cardiac malformation10.4MUC2, MUC5AC
31vulva basal cell carcinoma10.4KRT20, KRT7
32uterine disease10.4KRT7, MUC5AC
33persian gulf syndrome10.3KRT20, KRT7
34acidophil adenoma10.3MUC2, MUC5AC
35rete testis neoplasm10.3KRAS, KRT7
36vibratory urticaria10.3KRAS, KRT7
37gastric adenocarcinoma10.3KRAS, KRT7
38teratoma10.3
39mucinous cystadenocarcinoma10.3
40nerve fibre bundle defect10.3KRT20, KRT7
41acute cholangitis10.3CDX2, MUC2
42cystic teratoma10.2
43middle ear squamous cell carcinoma10.2KRT20, MUC6
44cystadenoma10.2
45mucinous adenocarcinoma of the appendix10.2
46appendix adenocarcinoma10.2CDX2, KRT20, MUC2
47tricuspid valve stenosis10.2KRAS, MUC5AC
48sensory system cancer10.2CDX2, KRT20, KRT7
49pulmonary neuroendocrine tumor10.2CDX2, KRT20, KRT7
50cellular phase chronic idiopathic myelofibrosis10.2CDX2, KRT20, KRT7

Graphical network of the top 20 diseases related to Pseudomyxoma Peritonei:



Diseases related to pseudomyxoma peritonei

Symptoms & Phenotypes for Pseudomyxoma Peritonei

About this section

Human phenotypes related to Pseudomyxoma Peritonei:

 64 54 (show all 17)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 ascites64 54 hallmark (90%) Very frequent (99-80%) HP:0001541
2 abnormality of the peritoneum64 54 hallmark (90%) Very frequent (99-80%) HP:0002585
3 abnormality of the abdominal wall64 54 hallmark (90%) Very frequent (99-80%) HP:0004298
4 inflammation of the large intestine64 54 typical (50%) Frequent (79-30%) HP:0002037
5 weight loss64 54 occasional (7.5%) Occasional (29-5%) HP:0001824
6 nausea and vomiting64 54 occasional (7.5%) Occasional (29-5%) HP:0002017
7 constipation64 54 occasional (7.5%) Occasional (29-5%) HP:0002019
8 abdominal pain64 54 occasional (7.5%) Occasional (29-5%) HP:0002027
9 respiratory insufficiency64 54 occasional (7.5%) Occasional (29-5%) HP:0002093
10 lymphadenopathy64 54 occasional (7.5%) Occasional (29-5%) HP:0002716
11 neoplasm of the pancreas64 occasional (7.5%) HP:0002894
12 intestinal obstruction64 54 occasional (7.5%) Occasional (29-5%) HP:0005214
13 neoplasm of the stomach64 occasional (7.5%) HP:0006753
14 abnormal renal physiology64 occasional (7.5%) HP:0012211
15 neoplasm of the colon64 occasional (7.5%) HP:0100273
16 ovarian neoplasm64 occasional (7.5%) HP:0100615
17 hernia64 54 occasional (7.5%) Occasional (29-5%) HP:0100790

UMLS symptoms related to Pseudomyxoma Peritonei:


cachexia, cancer pain, tumor pain, metastatic pain, breakthrough pain, hepatic hydrothorax

Drugs & Therapeutics for Pseudomyxoma Peritonei

About this section

Drugs for Pseudomyxoma Peritonei (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 40)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
leucovorinapprovedPhase 2, Phase 1108958-05-9143, 54575
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
2
Oxaliplatinapproved, investigationalPhase 2, Phase 1141261825-94-35310940, 9887054, 43805, 6857599, 9887054
Synonyms:
CHEMBL1201055
CID9887054
D01790
DACPLAT
Diaminocyclohexane Oxalatoplatinum
Eloxatin
Eloxatin (TN)
Elplat
Foloxatine
L-OHP
Oxalatoplatin
 
Oxalatoplatinum
Oxaliplatin (JAN/USAN/INN)
Oxaliplatin [Usan:Inn:Ban]
Oxaliplatino [Spanish]
Oxaliplatinum [Latin]
Oxaloplatine [French]
Oxaloplatino [Spanish]
Transplatin
oxaliplatin
oxaliplatine
oxaliplatino
oxaliplatinum
3
CisplatinapprovedPhase 2269015663-27-184093, 441203, 2767
Synonyms:
(SP-4-1)-diamminedichloridoplatinum
(SP-4-1)-diamminedichloroplatinum
(SP-4-2)-diamminedichloridoplatinum
(SP-4-2)-diamminedichloroplatinum
Abiplatin
Biocisplatinum
Briplatin
CACP
CDDP
CHEBI:35852
CID441203
CPD0-1392
CPDC
CPDD
Carboquone
Cis Pt II
Cis-DDP
Cis-Diaminedichloroplatinum
Cis-Diamminedichloroplatinum
Cismaplat
Cisplatine
Cisplatino
Cisplatinum
Cisplatyl
Citoplationo
DB00515
DDP
DDPT
Diamminedichloroplatinum
 
EU-0100918
Lederplatin
Neoplatin
Peyrone's chloride
Peyrone's salt
Plastin
Platamine
Platiblastin
Platidiam
Platinex
Platinol
Platinol-AQ
Platinoxan
Platinum Ammine Chloride
Platinum Ammonium Chloride
Platinum Diamine Dichloride
Randa
Trans-DDP
Trans-Diaminedichloroplatinum
Trans-Diamminedichloroplatinum
Trans-Dichlorodiammine Platinum
Trans-Platinumdiammine Dichloride
cis-DDP
cis-Diamminedichloroplatinum
cis-Dichlorodiammineplatinum(II)
cis-[PtCl2(NH3)2]
cis-diamminedichloridoplatinum(II)
cis-diamminedichloroplatinum(II)
nchembio773-comp1
trans-diamminedichloridoplatinum(II)
4
nivolumabapprovedPhase 2326946414-94-4
Synonyms:
BMS-936558
 
MDX-1106
ONO-4538
nivolumab
5
Amoxicillinapproved, vet_approvedPhase 244126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-╬▒-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
BRL-2333
BSPBio_000453
 
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
╬▒-amino-p-hydroxybenzylpenicillin
6
ClarithromycinapprovedPhase 227181103-11-984029
Synonyms:
(14R)-14-Hydroxyclarithromycin
116836-41-0
6-O-Methylerythromycin
6-O-Methylerythromycin a
6-O-methyl erythromycin
81103-11-9
A-56268
AC-6813
AC1L1HJO
AC1L36NJ
AC1NFSZE
AC1NR4MY
AC1NSJWH
AC1O52DV
AC1Q6O1T
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
BB_NC-1450
BIDD:GT0200
BSPBio_003453
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
Bio-0020
C06912
C2220
C30H54O11.C9H19NO2
CCRIS 8833
CHEBI:136451
CHEBI:3732
CHEMBL143
CHEMBL1741
CID10147055
CID10328822
CID11814635
CID11828745
CID11969952
CID4663848
CID489010
CID5284534
CID5311050
CID54688
CID6426662
CID84029
CID9810688
CID9811194
CLA
CLARITHROMYCIN
CLM & IL-12
CPD000466382
CRL-1605 & Clarithromycin
CTY
Clacine
Clambiotic
Claribid
Claricide
Clarith
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
 
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Cyllid
Cyllind
D00276
DRG-0099
DivK1c_006655
HMS1922H09
HMS2051G18
HMS2090O11
HMS2094M05
Helas
Heliclar
I05-0074
KBio1_001599
KBio2_000509
KBio2_003077
KBio2_005645
KBio3_002673
KBioGR_001218
KBioSS_000509
Klacid
Klaciped
Klaricid
Klaricid H.P
Klaricid H.P.
Klaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
LMPK04000014
LS-1812
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
MLS000759516
MLS001201751
MLS001424066
Mabicrol
Macladin
Maclar
Mavid
MolPort-002-507-425
MolPort-003-845-969
MolPort-005-910-192
MolPort-005-934-146
NCGC00178054-01
NSC643733
Naxy
O(6)-methylerythromycin
SAM001246748
SDP-015
SMR000466382
SPBio_001855
SPECTRUM1504231
STK801952
SpecPlus_000559
Spectrum2_001668
Spectrum3_001667
Spectrum4_000629
Spectrum5_001729
Spectrum_000089
TE-031
TE031
UNII-H1250JIK0A
Veclam
Zeclar
clarithromycin
clarithromycina
hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
7
Lansoprazoleapproved, investigationalPhase 2207103577-45-33883
Synonyms:
103577-45-3
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
A 65006
A-65006
AB00052388
ABT-006
AC1L1GX8
AG 1749
AG-1749
Abbot Brand of Lansoprazole
Agopton
Almirall Brand of Lansoprazole
Amarin
Aprazol
BIDD:GT0006
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
Bamalite
Bio-0824
Biuret
Biuret Gr
Biuret Reagent
Biuret Reagent Solution
Blason
C058687
C16H14F3N3O2S
CAS-103577-45-3
CG-4801
CHEBI:6375
CHEMBL480
CID3883
CPD000058469
Compraz
D00355
DB00448
Dakar
DivK1c_000920
EU-0100709
FT-0082011
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS502N22
HSDB 7204
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
I06-0018
IDI1_000920
Ilsatec
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
L 8533
L8533_SIGMA
LS-33080
Lancid
Lanfast
Lanproton
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole
Lansoprazole (JAN/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole [Usan:Ban:Inn]
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lanston
 
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Linamarin
Lopac-L-8533
Lopac0_000709
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
Mesactol
MolPort-003-666-508
MolPort-006-394-760
Monolitum
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-06
NCGC00015615-11
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NINDS_000920
Ogast
Ogastro
Opiren
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
PrevOnco
Prevacid
Prevacid (TN)
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid SoluTab
Prevacid Solutab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevpac
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
S1354_Selleck
SAM001246544
SMR000058469
SPBio_000488
SPBio_002992
SPECTRUM1503926
STK621169
Salvar Brand of Lansoprazole
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
Spectrum_001580
Suprecid
TAK 390MR
TAK-390MR
TAK390MR
TAP Brand of Lansoprazole
TL8000155
Takeda Brand of Lansoprazole
Takepron
Tecnobio Brand of Lansoprazole
UNII-0K5C5T2QPG
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton
lansoprazole
lansoprazole sulphone
lanzoprazole
8
FluorouracilapprovedPhase 2179151-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
9Immunosuppressive AgentsPhase 2, Phase 112770
10Anti-Infective AgentsPhase 2, Phase 121402
11Antimetabolites, AntineoplasticPhase 2, Phase 17171
12AntimetabolitesPhase 2, Phase 111774
13Antibiotics, AntitubercularPhase 26972
14AntacidsPhase 21767
15ImmunoglobulinsPhase 26045
16Anti-Bacterial AgentsPhase 210884
17AntibodiesPhase 26045
18
DexlansoprazolePhase 2207138530-94-6, 103577-45-39578005
Synonyms:
138530-94-6
CHEMBL1201863
CID9578005
D08903
Dexlansoprazole (INN/USAN)
KS-1075
 
Kapidex
MolPort-002-885-834
T 168390
TAK 390
UNII-UYE4T5I70X
ZINC00599734
dexlansoprazole
19Cytochrome P-450 Enzyme InhibitorsPhase 23822
20Cytochrome P-450 CYP3A InhibitorsPhase 21666
21Gastrointestinal AgentsPhase 28109
22
Proton pump inhibitorsPhase 21080
Synonyms:
 
PPIs
23Anti-Ulcer AgentsPhase 21767
24Antitubercular AgentsPhase 21272
25Antibodies, MonoclonalPhase 23795
26Alkylating AgentsPhase 24694
27Nucleic Acid Synthesis InhibitorsPhase 24855
28MitomycinsPhase 2233
29
LevoleucovorinapprovedPhase 171168538-85-2
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-formyltetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
 
(S)-Leucovorin
Citrovorum factor
L-Folinic acid
Levofolene
Levofolinic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
30
FloxuridineapprovedPhase 14850-91-95790
Synonyms:
1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil
1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil
1beta-D-2'-Deoxyribofuranosyl-5-flurouracil
2'-Deoxy-5-fluorouridine
5 Fluorodeoxyuridine
5-FUDR
5-Fluoro-2-desoxyuridine
5-Fluorodeoxyuridine
5-Fluorouracil 2'-deoxyriboside
5-Fluorouracil deoxyriboside
5FDU
Deoxyfluorouridine
 
FDUR
FDURD
FUDR
FdU
Floxiridina
Floxiridina [INN-Spanish]
Floxuridin
Floxuridine
Floxuridinum
Floxuridinum [INN-Latin]
Fluorodeoxyuridine
Fluoruridine Deoxyribose
WR-138720
beta-5-Fluoro-2'-deoxyuridine
31
GemcitabineapprovedPhase 1197495058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
32
CarboplatinapprovedPhase 1198041575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
33Protective AgentsPhase 17190
34Liver ExtractsPhase 13868
35pancreatic polypeptidePhase 120
36Calcium, DietaryPhase 15525
37Antiviral AgentsPhase 19732
38AntidotesPhase 11038
39ColaNutraceuticalPhase 11881
40Folinic AcidNutraceuticalPhase 13150

Interventional clinical trials:

(show all 16)
idNameStatusNCT IDPhase
1Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal OriginRecruitingNCT02387203Phase 2
2HIPEC Using High Intra-abdominal PressureRecruitingNCT02949791Phase 2
3Nivolumab and Ipilimumab in Treating Patients With Rare TumorsRecruitingNCT02834013Phase 2
4Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-CEnrolling by invitationNCT02040142Phase 2
5A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal CarcinomatosisTerminatedNCT00352755Phase 2
6Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerCompletedNCT01652794Phase 1
7Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNCT00005860Phase 1
8Results of CRS and Debulking in PMP PatientsUnknown statusNCT01427101
9Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346
10Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789
11Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma PeritoneiRecruitingNCT01946854
12Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was PerformedRecruitingNCT01617382
13Gastrointestinal Microbiome Study of Appendiceal CancerRecruitingNCT02599116
14Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesRecruitingNCT02073500
15French National Registry of Rare Peritoneal Surface MalignanciesActive, not recruitingNCT02834169
16Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC PatientsEnrolling by invitationNCT02374411

Search NIH Clinical Center for Pseudomyxoma Peritonei


Cochrane evidence based reviews: pseudomyxoma peritonei

Genetic Tests for Pseudomyxoma Peritonei

About this section

Anatomical Context for Pseudomyxoma Peritonei

About this section

MalaCards organs/tissues related to Pseudomyxoma Peritonei:

36
Appendix, Colon, Small intestine, Pancreas, Ovary, Liver, Testes

Publications for Pseudomyxoma Peritonei

About this section

Articles related to Pseudomyxoma Peritonei:

(show top 50)    (show all 565)
idTitleAuthorsYear
1
Synchronous Ovarian and Appendiceal Mucinous Neoplasms in the Absence of Pseudomyxoma Peritonei. (27870702)
2017
2
The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin. (27866811)
2017
3
Early Postoperative Intraperitoneal Chemotherapy for Low-Grade Appendiceal Mucinous Neoplasms with Pseudomyxoma Peritonei: Is it Beneficial? (27718032)
2017
4
Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei. (27038681)
2016
5
Incidence of leukopenia after intraperitoneal vs combined intravenous/intraperitoneal chemotherapy in pseudomyxoma peritonei. (27602245)
2016
6
Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. (26856956)
2016
7
Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei. (27646440)
2016
8
Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei? (26678404)
2016
9
Pseudomyxoma peritonei with intrathoracic extension: a rare disease with rarer presentation from low-grade mucinous adenocarcinoma of the appendix. (26729823)
2016
10
Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment. (26833741)
2016
11
Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel. (26933420)
2016
12
Appendicular mucinous adenocarcinoma associated with pseudomyxoma peritonei, a rare and difficult imaging diagnosis. (27239665)
2016
13
Advanced Pseudomyxoma Peritonei Requiring Gastrectomy to Achieve Complete Cytoreduction Results in Good Long-Term Oncologic Outcomes. (27380645)
2016
14
Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery? (27241925)
2016
15
A case of pseudomyxoma peritonei: visualization of septa using diffusion-weighted images with low b values. (26984750)
2016
16
Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei. (27065718)
2016
17
Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery. (26868165)
2016
18
A rare, low-grade appendiceal mucinous neoplasm (Pseudomyxoma peritonei) with ossification: A case report with morphoproteomic analysis of bone formation. (27712976)
2016
19
Mucinous Balls Tangled With Mesothelial Cells and MUC2-Positive Cancer Cells in the Ascites of Pseudomyxoma Peritonei. (27079739)
2016
20
Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study. (27352203)
2016
21
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours. (27065707)
2016
22
Incidentally discovered low-grade appendiceal mucinous neoplasm: a precursor to pseudomyxoma peritonei. (27980743)
2016
23
Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report. (27938333)
2016
24
Significance of epithelial cell clusters in pseudomyxoma peritonei. (27121698)
2016
25
FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei. (26907364)
2016
26
Pseudomyxoma Peritonei in a Patient with History of Breast Cancer. (26996187)
2016
27
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines. (25929336)
2015
28
Ovarian strumal carcinoid containing appendiceal-type mucinous tumor patterns presenting as pseudomyxoma peritonei. (25760904)
2015
29
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. (26492181)
2015
30
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus. (25572681)
2015
31
Pseudomyxoma peritonei extending to the lower extremity: a case report. (26187269)
2015
32
Management of pseudomyxoma peritonei. (26051332)
2015
33
The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). (26026742)
2015
34
Transformation of low-grade mucinous neoplasm of the appendix with pseudomyxoma peritonei to high-grade sarcomatoid carcinoma. (26015826)
2015
35
Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease. (25767403)
2015
36
Molecular profiles of high-grade and low-grade pseudomyxoma peritonei. (26475379)
2015
37
Palliative parenteral nutrition use in patients with intestinal failure as a consequence of advanced pseudomyxoma peritonei: a case series. (26105107)
2015
38
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus. (26714961)
2015
39
Ultrasonographic Features of Pseudomyxoma Peritonei and TheirComparison with Computed Tomographic Findings. (26564459)
2015
40
Pseudomyxoma peritonei diagnosed 19a88years after appendicectomy. (26494720)
2015
41
A rare cause of ascites: pseudomyxoma peritonei and a review of the literature. (25838904)
2015
42
Endometrial involvement in pseudomyxoma peritonei secondary to low-grade appendiceal mucinous neoplasm: report of 2 cases. (25760906)
2015
43
Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability? (26162922)
2015
44
Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix. (26254392)
2015
45
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei. (26193962)
2015
46
Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei. (25560600)
2015
47
Pseudomyxoma peritonei: a rare tumour mimicking primary ovarian neoplasia. (25743871)
2015
48
Elevated tumour markers are normalized in most patients with pseudomyxoma peritonei one week after complete tumour removal. (25704482)
2015
49
A New Etiology for the Abdominal Compartment Syndrome: Pseudomyxoma Peritonei. (26483617)
2015
50
Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei). (26489426)
2015

Variations for Pseudomyxoma Peritonei

About this section

Cosmic variations for Pseudomyxoma Peritonei:

8 (show all 46)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA Conf
1COSM521KRASperitoneum,appendix,other,pseudomyxoma peritoneic.35G>Ap.G12D5
2COSM532KRASperitoneum,appendix,other,pseudomyxoma peritoneic.38G>Ap.G13D5
3COSM539KRASperitoneum,appendix,other,pseudomyxoma peritoneic.44G>Ap.G15D5
4COSM520KRASperitoneum,appendix,other,pseudomyxoma peritoneic.35G>Tp.G12V5
5COSM527KRASperitoneum,appendix,other,pseudomyxoma peritoneic.37G>Tp.G13C5
6COSM4169147KRASperitoneum,appendix,other,pseudomyxoma peritoneic.412G>Ap.G138R5
7COSM27895GNASperitoneum,appendix,other,pseudomyxoma peritoneic.602G>Ap.R201H5
8COSM522KRASperitoneum,appendix,other,pseudomyxoma peritoneic.35G>Cp.G12A5
9COSM516KRASperitoneum,appendix,other,pseudomyxoma peritoneic.34G>Tp.G12C5
10COSM14122SMAD4peritoneum,appendix,other,pseudomyxoma peritoneic.1082G>Ap.R361H5
11COSM4169157SMAD2peritoneum,appendix,other,pseudomyxoma peritoneic.1391C>Tp.S464L5
12COSM10659TP53peritoneum,appendix,other,pseudomyxoma peritoneic.817C>Tp.R273C5
13COSM1035874VHLperitoneum,appendix,other,pseudomyxoma peritoneic.430G>Ap.G144R5
14COSM1360888KRASperitoneum,appendix,other,pseudomyxoma peritoneic.28G>Ap.G10R5
15COSM10771TP53peritoneum,appendix,other,pseudomyxoma peritoneic.749C>Tp.P250L5
16COSM27887GNASperitoneum,appendix,other,pseudomyxoma peritoneic.601C>Tp.R201C5
17COSM51382KRASperitoneum,appendix,other,pseudomyxoma peritoneic.50G>Ap.S17N5
18COSM529KRASperitoneum,appendix,other,pseudomyxoma peritoneic.37G>Cp.G13R5
19COSM33765AKT1peritoneum,appendix,other,pseudomyxoma peritoneic.49G>Ap.E17K5
20COSM517KRASperitoneum,appendix,other,pseudomyxoma peritoneic.34G>Ap.G12S5
21COSM4169137KRASperitoneum,appendix,other,pseudomyxoma peritoneic.418C>Tp.P140S5
22COSM302311GNASperitoneum,appendix,other,pseudomyxoma peritoneic.692G>Ap.R231H5
23COSM1570338RETperitoneum,appendix,other,pseudomyxoma peritoneic.2651A>Tp.E884V5
24COSM4169145GNASperitoneum,appendix,other,pseudomyxoma peritoneic.643G>Ap.D215N5
25COSM4169155GNASperitoneum,appendix,other,pseudomyxoma peritoneic.706C>Tp.Q236*5
26COSM1562184KRASperitoneum,appendix,other,pseudomyxoma peritoneic.25G>Ap.V9I5
27COSM1150828SMAD4peritoneum,appendix,other,pseudomyxoma peritoneic.1495T>Cp.C499R5
28COSM10648TP53peritoneum,appendix,other,pseudomyxoma peritoneic.524G>Ap.R175H5
29COSM580NRASperitoneum,appendix,other,pseudomyxoma peritoneic.181C>Ap.Q61K5
30COSM4169149KRASperitoneum,appendix,other,pseudomyxoma peritoneic.380C>Tp.T127I5
31COSM1685346GNASperitoneum,appendix,other,pseudomyxoma peritoneic.677G>Ap.G226D5
32COSM4169159GNASperitoneum,appendix,other,pseudomyxoma peritoneic.596G>Ap.R199H5
33COSM4386691ATMperitoneum,appendix,other,pseudomyxoma peritoneic.3980T>Gp.L1327*5
34COSM4169153KRASperitoneum,appendix,other,pseudomyxoma peritoneic.389C>Tp.A130V5
35COSM10777TP53peritoneum,appendix,other,pseudomyxoma peritoneic.715A>Gp.N239D5
36COSM1169214KRASperitoneum,appendix,other,pseudomyxoma peritoneic.101C>Tp.P34L5
37COSM1150895SMAD4peritoneum,appendix,other,pseudomyxoma peritoneic.1157G>Ap.G386D5
38COSM12591PIK3CAperitoneum,appendix,other,pseudomyxoma peritoneic.3127A>Gp.M1043V5
39COSM546KRASperitoneum,colon,other,pseudomyxoma peritoneic.175G>Ap.A59T5
40COSM763PIK3CAperitoneum,appendix,other,pseudomyxoma peritoneic.1633G>Ap.E545K5
41COSM4755600PDGFRAperitoneum,appendix,other,pseudomyxoma peritoneic.1658C>Tp.P553L5
42COSM3727814KRASperitoneum,appendix,other,pseudomyxoma peritoneic.91G>Ap.E31K5
43COSM99221GNASperitoneum,appendix,other,pseudomyxoma peritoneic.602G>Tp.R201L5
44COSM4169161KRASperitoneum,appendix,other,pseudomyxoma peritoneic.59C>Tp.T20M0
45COSM110699KRASperitoneum,appendix,other,pseudomyxoma peritoneic.29G>Ap.G10E0
46COSM4169135SMAD2peritoneum,appendix,other,pseudomyxoma peritoneic.1388G>Ap.C463Y0

Expression for genes affiliated with Pseudomyxoma Peritonei

About this section
Search GEO for disease gene expression data for Pseudomyxoma Peritonei.

Pathways for genes affiliated with Pseudomyxoma Peritonei

About this section

GO Terms for genes affiliated with Pseudomyxoma Peritonei

About this section

Cellular components related to Pseudomyxoma Peritonei according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Golgi lumenGO:00057968.2MUC1, MUC2, MUC5AC, MUC6

Biological processes related to Pseudomyxoma Peritonei according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1maintenance of gastrointestinal epitheliumGO:003027710.1MUC2, MUC6
2striated muscle cell differentiationGO:00511469.5CDH2, KRAS
3O-glycan processingGO:00162668.5MUC1, MUC2, MUC5AC, MUC6

Sources for Pseudomyxoma Peritonei

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet